Health
Targeted therapies could exploit unique metabolic features of pancreatic cancer cells – News-Medical.Net
Probing the unique biology of human pancreatic cancer cells in a laboratory has yielded unexpected insights of a weakness that can be used against the cells to…
Probing the unique biology of human pancreatic cancer cells in a laboratory has yielded unexpected insights of a weakness that can be used against the cells to kill them.
Led by Princess Margaret Cancer Centre (PM) Scientist Dr. Marianne Koritzinsky, researchers showed that about half of patient-derived pancreatic cancer cell lines are highly dependent or “addicted” to the protein peroxiredoxin 4 (PRDX4), as a result of the altered metabolic state of the cancer cell.
This addiction is vital for…
-
Business21 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News18 hours agoWilliam Robinson dies aged 89
-
General17 hours agoCalls for corruption probe into completion of mayor’s Surfers Paradise Bowls Club site purchase
-
Business19 hours agoTop brokers name 3 ASX shares to buy today 27 August 2025